The first drug to treat low sexual desire in women won approval from US
health regulators on Tuesday Aug 18,2015, but with a warning about potentially
dangerous low blood pressure and fainting side effects, especially when
taken with alcohol.
The US Food and Drug Administration(FDA) said the pink pill, to be sold under the brand name Addyi and made by privately held Sprout Pharmaceuticals, will only be available through certified and specially trained health care professionals and pharmacies due to its safety issues.
Addyi,
whose chemical name is flibanserin, is designed for premenopausal women
whose lack of sexual desire causes distress. The condition is formally
known as hypoactive sexual desire disorder, or HSDD.The US Food and Drug Administration(FDA) said the pink pill, to be sold under the brand name Addyi and made by privately held Sprout Pharmaceuticals, will only be available through certified and specially trained health care professionals and pharmacies due to its safety issues.
No comments:
Post a Comment